Table of Contents

1 Study Coverage

• 1.1 Alpha Synuclein Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Alpha Synuclein Market Size Growth Rate by Product
  • 1.4.2 AV-1950R
  • 1.4.3 AV-1947D
  • 1.4.4 BAN-0805
  • 1.4.5 BIIB-054
  • 1.4.6 DPC-003
  • 1.4.7 Others
• 1.5 Market by End User
  • 1.5.1 Global Alpha Synuclein Market Size Growth Rate by End User
  • 1.5.2 Multiple System Atrophy
  • 1.5.3 Neurodegenerateive Disease
  • 1.5.4 Lewy Body Dementia
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Alpha Synuclein Market Size
  • 2.1.1 Global Alpha Synuclein Revenue 2014-2025
  • 2.1.2 Global Alpha Synuclein Sales 2014-2025
• 2.2 Alpha Synuclein Growth Rate by Regions
  • 2.2.1 Global Alpha Synuclein Sales by Regions
  • 2.2.2 Global Alpha Synuclein Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Alpha Synuclein Sales by Manufacturers
  • 3.1.1 Alpha Synuclein Sales by Manufacturers
  • 3.1.2 Alpha Synuclein Sales Market Share by Manufacturers
  • 3.1.3 Global Alpha Synuclein Market Concentration Ratio (CR5 and HHI)
• 3.2 Alpha Synuclein Revenue by Manufacturers
  • 3.2.1 Alpha Synuclein Revenue by Manufacturers (2014-2019)
  • 3.2.2 Alpha Synuclein Revenue Share by Manufacturers (2014-2019)
• 3.3 Alpha Synuclein Price by Manufacturers
• 3.4 Alpha Synuclein Manufacturing Base Distribution, Product Types
  • 3.4.1 Alpha Synuclein Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Alpha Synuclein Product Type
  • 3.4.3 Date of International Manufacturers Enter into Alpha Synuclein Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Alpha Synuclein Sales by Product
• 4.2 Global Alpha Synuclein Revenue by Product
• 4.3 Alpha Synuclein Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Alpha Synuclein Breakdown Data by End User

6 North America

• 6.1 North America Alpha Synuclein by Countries
  • 6.1.1 North America Alpha Synuclein Sales by Countries
  • 6.1.2 North America Alpha Synuclein Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Alpha Synuclein by Product
• 6.3 North America Alpha Synuclein by End User

7 Europe

• 7.1 Europe Alpha Synuclein by Countries
  • 7.1.1 Europe Alpha Synuclein Sales by Countries
  • 7.1.2 Europe Alpha Synuclein Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Alpha Synuclein by Product
• 7.3 Europe Alpha Synuclein by End User

8 Asia Pacific

• 8.1 Asia Pacific Alpha Synuclein by Countries
  • 8.1.1 Asia Pacific Alpha Synuclein Sales by Countries
  • 8.1.2 Asia Pacific Alpha Synuclein Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Alpha Synuclein by Product
• 8.3 Asia Pacific Alpha Synuclein by End User

9 Central & South America

• 9.1 Central & South America Alpha Synuclein by Countries
  • 9.1.1 Central & South America Alpha Synuclein Sales by Countries
  • 9.1.2 Central & South America Alpha Synuclein Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Alpha Synuclein by Product
• 9.3 Central & South America Alpha Synuclein by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Alpha Synuclein by Countries
  • 10.1.1 Middle East and Africa Alpha Synuclein Sales by Countries
  • 10.1.2 Middle East and Africa Alpha Synuclein Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Alpha Synuclein by Product
• 10.3 Middle East and Africa Alpha Synuclein by End User

11 Company Profiles

• 11.1 AC Immune SA
  • 11.1.1 AC Immune SA Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 AC Immune SA Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 AC Immune SA Alpha Synuclein Products Offered
  • 11.1.5 AC Immune SA Recent Development
• 11.2 AFFiRiS AG
  • 11.2.1 AFFiRiS AG Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 AFFiRiS AG Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 AFFiRiS AG Alpha Synuclein Products Offered
  • 11.2.5 AFFiRiS AG Recent Development
• 11.3 BioArctic AB
  • 11.3.1 BioArctic AB Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 BioArctic AB Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 BioArctic AB Alpha Synuclein Products Offered
  • 11.3.5 BioArctic AB Recent Development
• 11.4 Biogen Inc
  • 11.4.1 Biogen Inc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Biogen Inc Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Biogen Inc Alpha Synuclein Products Offered
  • 11.4.5 Biogen Inc Recent Development
• 11.5 Evotec AG
  • 11.5.1 Evotec AG Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Evotec AG Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Evotec AG Alpha Synuclein Products Offered
  • 11.5.5 Evotec AG Recent Development
• 11.6 Genmab A/S
  • 11.6.1 Genmab A/S Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Genmab A/S Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Genmab A/S Alpha Synuclein Products Offered
  • 11.6.5 Genmab A/S Recent Development
• 11.7 H. Lundbeck A/S
  • 11.7.1 H. Lundbeck A/S Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 H. Lundbeck A/S Alpha Synuclein Products Offered
  • 11.7.5 H. Lundbeck A/S Recent Development
• 11.8 ICB International Inc
  • 11.8.1 ICB International Inc Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 ICB International Inc Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 ICB International Inc Alpha Synuclein Products Offered
  • 11.8.5 ICB International Inc Recent Development
• 11.9 MedImmune LLC
  • 11.9.1 MedImmune LLC Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 MedImmune LLC Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 MedImmune LLC Alpha Synuclein Products Offered
  • 11.9.5 MedImmune LLC Recent Development
• 11.10 Neuropore Therapies Inc
  • 11.10.1 Neuropore Therapies Inc Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Neuropore Therapies Inc Alpha Synuclein Products Offered
  • 11.10.5 Neuropore Therapies Inc Recent Development
• 11.11 nLife Therapeutics SL
• 11.12 Prothena Corp Plc
• 11.13 QR Pharma Inc
• 11.14 reMYND NV

12 Future Forecast

• 12.1 Alpha Synuclein Market Forecast by Regions
  • 12.1.1 Global Alpha Synuclein Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Alpha Synuclein Revenue Forecast by Regions 2019-2025
• 12.2 Alpha Synuclein Market Forecast by Product
  • 12.2.1 Global Alpha Synuclein Sales Forecast by Product 2019-2025
  • 12.2.2 Global Alpha Synuclein Revenue Forecast by Product 2019-2025
• 12.3 Alpha Synuclein Market Forecast by End User
• 12.4 North America Alpha Synuclein Forecast
• 12.5 Europe Alpha Synuclein Forecast
• 12.6 Asia Pacific Alpha Synuclein Forecast
• 12.7 Central & South America Alpha Synuclein Forecast
• 12.8 Middle East and Africa Alpha Synuclein Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Alpha Synuclein Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Alpha Synuclein market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alpha Synuclein market based on company, product type, end user and key regions.

This report studies the global market size of Alpha Synuclein in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alpha Synuclein in these regions.
This research report categorizes the global Alpha Synuclein market by top players/brands, region, type and end user. This report also studies the global Alpha Synuclein market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AC Immune SA
AFFiRiS AG
BioArctic AB
Biogen Inc
Evotec AG
Genmab A/S
H. Lundbeck A/S
ICB International Inc
MedImmune LLC
Neuropore Therapies Inc
nLife Therapeutics SL
Prothena Corp Plc
QR Pharma Inc
reMYND NV

Market size by Product
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others
Market size by End User
Multiple System Atrophy
Neurodegenerateive Disease
Lewy Body Dementia
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Alpha Synuclein market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Alpha Synuclein market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alpha Synuclein companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alpha Synuclein submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Alpha Synuclein are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alpha Synuclein market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.